Clinical Trials

Hepatitis B Virus (HBV) Infection Hepatitis C Virus (HCV) Infection Tuberculosis (TB)

Aging and HIV Infection Cardiovascular Effects Dementia Depression Gastrointestinal (GI) Problems Hepatic (Liver) Complications/Damage Hyperglycemia or Hypoglycemia Hyperlipidemia Lipodystrophy Metabolic Syndrome Neurological Complications/Damage Oral Complications/Diseases Osteonecrosis, Osteopenia, or Osteoporosis Pulmonary (Lung) Complications/Diseases Renal (Kidney) Complications/Damage Skin Diseases

Abacavir Atazanavir Atripla Cobicistat Combivir Complera Darunavir Descovy Didanosine Dolutegravir Efavirenz Elvitegravir Emtricitabine Enfuvirtide Epzicom Etravirine Evotaz Fosamprenavir Genvoya Indinavir Kaletra Lamivudine Maraviroc Nelfinavir Nevirapine Odefsey Prezcobix Raltegravir Rilpivirine Ritonavir Saquinavir Stavudine Stribild Tenofovir Disoproxil Fumarate Tipranavir Triumeq Trizivir Truvada Zidovudine

Acyclovir Albendazole Amphotericin B Azithromycin Butoconazole Nitrate Capreomycin Ciprofloxacin Clarithromycin Clindamycin Daclatasvir Elbasvir / Grazoprevir Ethambutol Hydrochloride Famciclovir Fluconazole Flucytosine Foscarnet Sodium Ganciclovir Harvoni Hepatitis A and Hepatitis B (Recombinant) Vaccine Hepatitis B Vaccine Human Papillomavirus 9 Valent (Types 6, 11, 16, 18, 31, 33, 45, 52, 58) Vaccine, Recombinant Human Papillomavirus Bivalent (Types 16 and 18) Vaccine, Recombinant Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant Imiquimod Isoniazid Itraconazole Levofloxacin Miconazole Moxifloxacin Hydrochloride Peginterferon Alfa-2a Peginterferon Alfa-2b Primaquine Phosphate Pyrazinamide Pyrimethamine Ribavirin Rifabutin Rifampin Simeprevir Sinecatechins Sofosbuvir Sulfadiazine Sulfamethoxazole / Trimethoprim Terconazole Valacyclovir Hydrochloride Valganciclovir Hydrochloride Vancomycin Hydrochloride VariZIG Varicella Virus Vaccine Live Viekira Pak Voriconazole

3BNC117 AGS-004 AMD-070 Aldesleukin Amdoxovir Apricitabine Astodrimer BMS-955176 Bictegravir CYT-107 Cabotegravir Carbopol 974P Carrageenan Cenicriviroc Censavudine Chloroquine Dapivirine Dexelvucitabine Disulfiram Doravirine Elvucitabine Fosdevirine Fostemsavir GTU-MultiHIV B Hydroxychloroquine INCB-9471 Ibalizumab KP-1461 LIPO-5 Lefitolimod Lersivirine Lexgenleucel-T Losartan MPC-4326 Maraviroc (HIV prevention) Monomeric DAPTA PRO-140 PRO-2000 PSI-5004 Panobinostat Peginterferon Alfa-2a (HIV) Peginterferon Alfa-2b (HIV) Poly-ICLC Rilpivirine LA Rintatolimod Romidepsin SB-728-T THV01 TMC-310911 Tat Oyi Tenofovir (Microbicide) Tenofovir Alafenamide Tucaresol UB-421 VM-1500 Vac-3S Vacc-4x Valproic Acid Vicriviroc Vorinostat

Aspergillosis Bacterial Enteric Infections Bacterial Respiratory Disease Bartonellosis Candidiasis (Thrush) Chagas Disease Coccidioidomycosis Cryptococcosis Cryptosporidiosis Cytomegalovirus (CMV) Hepatitis B Virus (HBV) Infection Hepatitis C Virus (HCV) Infection Herpes Simplex Virus (HSV) Histoplasmosis Human Herpesvirus-6 and -7 (HHV-6, HHV-7) Human Herpesvirus-8 (HHV-8) Human Papillomavirus Disease (HPV) Isosporiasis Leishmaniasis Malaria Microsporidiosis Mycobacterium avium Complex (MAC) Penicilliosis marneffei Pneumocystis Pneumonia (PCP) Progressive Multifocal Leukoencephalopathy (PML) Syphilis Toxoplasmosis Varicella-Zoster Virus (Chickenpox/Shingles)

HIV Prevention in Substance Users HIV Preventive Vaccines Male Circumcision Microbicides Post-Exposure Prophylaxis (PEP) Pre-Exposure Prophylaxis (PrEP) Prevention of Mother-to-Child Transmission (PMTCT)

African Americans Asian and Pacific Islanders Children/Adolescents Discordant Couples Female Only Hispanics/Latinos Lesbian, Gay, Bisexual, Transgendered (LGBT) Community Long-Term Nonprogressers/Elite Controllers Male Only Men who have Sex with Men (MSM) Native Americans (American Indians, Alaska Natives, and Native Hawaiians) Older Adults Prisoners and Inmates Substance Users

Acute/Early Infection Bone Marrow and Stem Cell Transplantation Complementary and Alternative Medicine Expanded Access Studies Gene Therapy HIV Therapeutic Vaccines Treatment Adherence Treatment Failure Treatment-Experienced Patients Treatment-Naive Patients

Adolescents and Children (birth to 17) Adults (18-65) Seniors (65 and older)

Behavioral Expanded Access Interventional Observational

HIV Preventive Vaccines HIV Therapeutic Vaccines